Fraser Inglis

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

Daniel K. Burns, Robert Alexander, Kathleen A. Welsh‐Bohmer et al. · The Lancet Neurology · 2021 · 117 citations

Medicine, Pharmacology, Pharmacotherapy +14

Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment

David A. Wolk, Carl Sadowsky, Beth Safirstein et al. · JAMA Neurology · 2018 · 87 citations · Full text

Medicine, Neurology, Neuroscience +17

The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss.

Lawrence Worobetz, Fraser Inglis, Eldon A. Shaffer · PubMed · 1993 · 84 citations

Agriculture, Pharmacotherapy, Surgery +15

Effect of ispronicline, a neuronal nicotinic acetylcholine receptor partial agonist, in subjects with age associated memory impairment (AAMI)

G. C. Dunbar, Fraser Inglis, Ramana Kuchibhatla et al. · Journal of Psychopharmacology · 2007 · 75 citations

Medicine, Pharmacology, Pharmacotherapy +16

Clinical usefulness of dopamine transporter SPECT imaging with ¹²³I-FP-CIT in patients with possible dementia with Lewy bodies: Randomised study

Zuzana Walker, Emilio Moreno, Alan Thomas et al. · The British Journal of Psychiatry · 2014 · 56 citations · Full text

Medicine, Neurology, Nuclear Medicine +17